LabCompass

James C. Stock

Medicine · The Ohio State University

OpenAlex ORCID
Mid career · publishing since 2014Rising activity
Research on Leishmaniasis StudiesCancer survivorship and careParasites and Host InteractionsTrypanosoma species research and implicationsChemotherapy-induced cardiotoxicity and mitigation

Publications

13

Citations

89

Est. group size

~3

Recurring co-author estimate

Active years

11

Publishing since 2014

Research summary
AI-generated

James C. Stock's publicly recorded work spans several distinct topics, including immune responses in parasitic infections like leishmaniasis, sex-related differences in T cell signaling, cardiotoxicity from chemotherapy, and clinical case reports involving drug side effects and cardiac procedures. The publication record suggests a mix of basic immunology research and clinical/case-based medical reporting rather than a single tightly focused research program.

Immune responses to parasitic infections (e.g., leishmaniasis)Sex differences in immune cell signalingDrug-related side effects and case reportsCardiac procedure safety (e.g., biopsy, anticoagulants)Chemotherapy-related cardiotoxicity

Publication output has been irregular over the last decade, with several gap years followed by a recent increase in 2023 and 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.2/year recently
2017: 1 publication17182019: 1 publication19202021: 1 publication21222023: 3 publications3232024: 3 publications3242526
Recent publications
Publishes in
  • The Journal of Immunology×1
  • Cancer Medicine×1
  • JMIR Cancer×1
  • Cellular Immunology×1
  • Journal of Pharmacy Practice×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile